A compelling piece was published in Forbes Magazine recently. Adriana Jenkins, who passed away this month, writes from the perspective of a dying cancer patient to advocate for the passing of a law to encourage drug makers to developed Personalized Medicine drugs for cancer and other deadly diseases. Her perspective, as both a patient and an individual who worked in biotech for 15 years, is both unique and moving.
A Cancer Patient’s Plea for Personalized Medicine
Tagged with: Personalized health care